Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion
AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiogr...
Ausführliche Beschreibung
Autor*in: |
Chong Zhang [verfasserIn] Tong-Tong Niu [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2016 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Guoji Yanke Zazhi - Press of International Journal of Ophthalmology (IJO PRESS), 2017, 16(2016), 4, Seite 702-705 |
---|---|
Übergeordnetes Werk: |
volume:16 ; year:2016 ; number:4 ; pages:702-705 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.3980/j.issn.1672-5123.2016.4.28 |
---|
Katalog-ID: |
DOAJ033386382 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ033386382 | ||
003 | DE-627 | ||
005 | 20230502092330.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3980/j.issn.1672-5123.2016.4.28 |2 doi | |
035 | |a (DE-627)DOAJ033386382 | ||
035 | |a (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RE1-994 | |
100 | 0 | |a Chong Zhang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. | ||
650 | 4 | |a branch retinal vein occlusion | |
650 | 4 | |a macular edema | |
650 | 4 | |a ranibizumab | |
650 | 4 | |a grid pattern laser photocoagulation | |
653 | 0 | |a Ophthalmology | |
700 | 0 | |a Tong-Tong Niu |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Guoji Yanke Zazhi |d Press of International Journal of Ophthalmology (IJO PRESS), 2017 |g 16(2016), 4, Seite 702-705 |w (DE-627)1680946854 |x 16725123 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2016 |g number:4 |g pages:702-705 |
856 | 4 | 0 | |u https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 |z kostenfrei |
856 | 4 | 0 | |u http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1672-5123 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1672-5123 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_2817 | ||
951 | |a AR | ||
952 | |d 16 |j 2016 |e 4 |h 702-705 |
author_variant |
c z cz t t n ttn |
---|---|
matchkey_str |
article:16725123:2016----::fetfaiiuawtmclrrdatrpooogltofrauaeeaasd |
hierarchy_sort_str |
2016 |
callnumber-subject-code |
RE |
publishDate |
2016 |
allfields |
10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705 |
spelling |
10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705 |
allfields_unstemmed |
10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705 |
allfieldsGer |
10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705 |
allfieldsSound |
10.3980/j.issn.1672-5123.2016.4.28 doi (DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 DE-627 ger DE-627 rakwb eng RE1-994 Chong Zhang verfasserin aut Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion 2016 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology Tong-Tong Niu verfasserin aut In Guoji Yanke Zazhi Press of International Journal of Ophthalmology (IJO PRESS), 2017 16(2016), 4, Seite 702-705 (DE-627)1680946854 16725123 nnns volume:16 year:2016 number:4 pages:702-705 https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 kostenfrei https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 kostenfrei http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei https://doaj.org/toc/1672-5123 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 AR 16 2016 4 702-705 |
language |
English |
source |
In Guoji Yanke Zazhi 16(2016), 4, Seite 702-705 volume:16 year:2016 number:4 pages:702-705 |
sourceStr |
In Guoji Yanke Zazhi 16(2016), 4, Seite 702-705 volume:16 year:2016 number:4 pages:702-705 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation Ophthalmology |
isfreeaccess_bool |
true |
container_title |
Guoji Yanke Zazhi |
authorswithroles_txt_mv |
Chong Zhang @@aut@@ Tong-Tong Niu @@aut@@ |
publishDateDaySort_date |
2016-01-01T00:00:00Z |
hierarchy_top_id |
1680946854 |
id |
DOAJ033386382 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033386382</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502092330.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033386382</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Chong Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">branch retinal vein occlusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">macular edema</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ranibizumab</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">grid pattern laser photocoagulation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tong-Tong Niu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">16(2016), 4, Seite 702-705</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:702-705</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">702-705</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Chong Zhang |
spellingShingle |
Chong Zhang misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion |
authorStr |
Chong Zhang |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)1680946854 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RE1-994 |
illustrated |
Not Illustrated |
issn |
16725123 |
topic_title |
RE1-994 Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion branch retinal vein occlusion macular edema ranibizumab grid pattern laser photocoagulation |
topic |
misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology |
topic_unstemmed |
misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology |
topic_browse |
misc RE1-994 misc branch retinal vein occlusion misc macular edema misc ranibizumab misc grid pattern laser photocoagulation misc Ophthalmology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Guoji Yanke Zazhi |
hierarchy_parent_id |
1680946854 |
hierarchy_top_title |
Guoji Yanke Zazhi |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)1680946854 |
title |
Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion |
ctrlnum |
(DE-627)DOAJ033386382 (DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21 |
title_full |
Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion |
author_sort |
Chong Zhang |
journal |
Guoji Yanke Zazhi |
journalStr |
Guoji Yanke Zazhi |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2016 |
contenttype_str_mv |
txt |
container_start_page |
702 |
author_browse |
Chong Zhang Tong-Tong Niu |
container_volume |
16 |
class |
RE1-994 |
format_se |
Elektronische Aufsätze |
author-letter |
Chong Zhang |
doi_str_mv |
10.3980/j.issn.1672-5123.2016.4.28 |
author2-role |
verfasserin |
title_sort |
effect of ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion |
callnumber |
RE1-994 |
title_auth |
Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion |
abstract |
AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. |
abstractGer |
AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. |
abstract_unstemmed |
AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ SSG-OLC-PHA GBV_ILN_11 GBV_ILN_2817 |
container_issue |
4 |
title_short |
Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion |
url |
https://doi.org/10.3980/j.issn.1672-5123.2016.4.28 https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21 http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf https://doaj.org/toc/1672-5123 |
remote_bool |
true |
author2 |
Tong-Tong Niu |
author2Str |
Tong-Tong Niu |
ppnlink |
1680946854 |
callnumber-subject |
RE - Ophthalmology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3980/j.issn.1672-5123.2016.4.28 |
callnumber-a |
RE1-994 |
up_date |
2024-07-03T17:28:22.158Z |
_version_ |
1803579767822221312 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033386382</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230502092330.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033386382</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ9ea13bcdbe9840a582851bed20fb9e21</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RE1-994</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Chong Zhang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effect of Ranibizumab with macular grid pattern photocoagulation for macular edema caused by branch retinal vein occlusion</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">AIM:To evaluate the effect of Ranibizumab(lucentis)combined with macular grid pattern photocoagulation in the treatment of macular edema caused by branch retinal vein occlusion(BRVO). <p<METHODS:Forty-two patients(42 eyes)diagnosed as macular edema caused by BRVO by fundus fluorescence angiography(FFA)and optical coherence tomography(OCT)were enrolled. The patients were randomized divided into two groups:group 1(combined therapy group)received lucentis intravitreal injection combined with macular grid pattern photocoagulation; group 2(photocoagulation therapy group)received macular grid pattern photocoagulation only. The best corrected visual activity(BCVA), central macular thickness(CMT)and complications were compared between the two groups at 1, 3 and 6mo after treatments. <p<RESULTS:Compared to before treatments, at 1, 3 and 6mo after treatments:the changes of BCVA and CMT were significant different in group 1(<i<P</i<<0. 05). Compared with before treatments, at 1mo after treatments:changes of BCVA and CMT had no significant differences in group 2(<i<P</i<<0. 05); but at 3 and 6mo after treatments:BCVA and CMT improved gradually and the differences were significant in group 2(<i<P</i<<0. 05).The changes of BCVA and CMT between the two groups were statistically significant at 1, 3 and 6mo after treatments(<i<P</i<<0.05). <p<CONCLUSION:Ranibizumab intravitreal injection combined with macular grid pattern photocoagulation therapy can effectively reduce macular edema caused by BRVO, improve vision acuity. Compared with macular grid pattern photocoagulation therapy, combination therapy works more quickly, and reduces macular edema more.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">branch retinal vein occlusion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">macular edema</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ranibizumab</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">grid pattern laser photocoagulation</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Ophthalmology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Tong-Tong Niu</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Guoji Yanke Zazhi</subfield><subfield code="d">Press of International Journal of Ophthalmology (IJO PRESS), 2017</subfield><subfield code="g">16(2016), 4, Seite 702-705</subfield><subfield code="w">(DE-627)1680946854</subfield><subfield code="x">16725123</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:16</subfield><subfield code="g">year:2016</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:702-705</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3980/j.issn.1672-5123.2016.4.28</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/9ea13bcdbe9840a582851bed20fb9e21</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://ies.ijo.cn/cn_publish/2016/4/201604028.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1672-5123</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2817</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">16</subfield><subfield code="j">2016</subfield><subfield code="e">4</subfield><subfield code="h">702-705</subfield></datafield></record></collection>
|
score |
7.397518 |